"Why does cancer come back and how to fight it?"

Ana Luísa Correia, Cancer Dormancy & Immunity
 

"The quick and the dead: a tale of resident memory T cells in infection and cancer"

Klaas van Gisbergen, Tissue Immunity
 

Moderation

Leopoldo Petreanu, Cortical Circuits

Host

Christa Rhiner, PhD, Stem Cells and Regeneration Lab

Venue

Seminar Room

Currently, the reference standard treatment for locally advanced rectal cancer, meaning tumours that have grown deeper into the layers of the rectal wall and/or involved nearby lymph nodes, but have not yet spread to the rest of the body – is to submit patients to chemotherapy and radiotherapy before surgery. This “total neoadjuvant therapy” reduces the risk of the cancer coming back in the rectum and can lower the risk of metastases, but has a cost for the patients because of the detrimental effects of radiation. 

Offer Description

As a partner institution of the INTEGRATE Consortium and the PsyPal Consortium, we are recruiting a PhD student in the topic of 'Psychotherapy process and psychological intervention techniques in psychedelic therapy: safety and efficacy'.This student will join the Neuropsychiatry Unit, supervised by Albino J. Oliveira-Maia and Carolina Seybert. 

A long-standing friend and collaborator of the Champalimaud Foundation, he played a decisive role in the global recognition of vision science and in strengthening the connection between research, clinical practice, and innovation.

Professor Parreira, Clinical Director of the Champalimaud Clinical Centre since its founding, was distinguished by the President of the Portuguese Republic, Marcelo Rebelo de Sousa, with the rank of Grand Officer of the Order of Public Instruction. The ceremony took place in Palácio de Belém on the 14th of january, 2026.

Host

Adriana Sánchez Danés, PhD, Cancer and Stem Cell Biology Lab

Venue

Seminar room

Abstract

In this seminar, I will present recent advances developed in our laboratory in CAR-based adoptive T-cell immunotherapy, with a particular focuss on leukemia. The talk will highlight γδ T cells as allogeneic effector platforms and explore emerging dual-targeting and armored CAR strategies.

Join us in Lisbon this October for the 3rd Botton Champalimaud International Pancreatic Cancer Conference, where leading experts from around the world will come together to shape the future of pancreatic cancer care and research.

This year's conference will focus on Locally Advanced and Metastatic Pancreatic Cancer, showcasing the latest translational discoveries, clinical breakthroughs, advanced surgical techniques, and innovative therapeutic strategies.

The Lucerne Consortium, a multidisciplinary group of European cancer societies and researchers that creates guidelines for early breast cancer care, published, in the December issue of the journal The Lancet Oncology, the conclusions of its Lucerne Toolbox 3 initiative, which pave the way to better treatment for patients in early stages of breast cancer.

The Lucerne consortium has already presented consensus recommendations for locoregional therapy after primary systemic therapy and for axillary management in early breast cancer. Now comes the turn of digital tools and AI.

Host

Carlos Ribeiro, PhD, Behavior and Metabolism

Venue

Seminar room